Abstract
To the Editor We read with interest the report by Tatsas et al1 documenting practice patterns of cervical cancer screening and human papillomavirus (HPV) cotesting. The authors noticed a trend of increased adoption of age-appropriate cotesting in women 30 years and older, and a persistence of age-inappropriate cotesting in women younger than 30 years. We performed a comparable study at our institution, a rural practice with a low incidence of cervical cancer, and found disappointing, yet similar, results. We evaluated the ordering practices of providers by analyzing the number of Papanicolaou (Pap) tests performed with and without accompanying HPV orders for 2 age groups: women younger than …
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
